原发肿瘤生物学可预测结直肠肝转移切除后的复发与生存:BIO-CRLM 研究启示

Primary Tumor Biology Predicts Recurrence and Survival Outcomes After Colorectal Liver Metastasis Resection: Insights from the BIO-CRLM Study

The BIO-CRLM study demonstrates that integrating primary tumor location with RAS/BRAF mutation status defines distinct recurrence patterns and survival outcomes after colorectal liver metastasis resection, enabling improved prognostication and personalized patient management.